The review also highlights that the early diagnosis of RA and evaluation of inflammatory markers like anti-citrullinated peptides, ESR, and CRP are crucial, and early treatment with anti-inflammatory drugs in RA patients can reduce the development of complications like HF. The gene discussed is CRP; the disease is rheumatoid arthritis.